December 27, 2024
2 min watch
Save
VIDEO: Menin inhibitors could significantly change leukemia treatment
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Catherine Lai, MD, MPH discusses the results of a study presented at ASH Annual Meeting that examined the use of a new class of menin inhibitors on two different types of mutated acute myeloid leukemia.
Lai, an assistant professor of clinical medicine at the University of Pennsylvania, highlighted the study, and further discussed how combination therapy of menin inhibitors could drive the treatment of leukemia in the future.
“I think what will come will be how we sequence these drugs, and more importantly, how we use these drugs in combination now in the newly diagnosed setting,” Lai said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Lai reports serving on an advisory board for Astellas, BMS, Daiichi, Genentech and Servier, consulting for AbbVie and Rigel, and receiving research funding from BMS and Jazz.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.